UROV Gross Margin

The Gross Margin of Urovant Sciences Ltd (UROV) is N/A.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

UROV Gross Margin - Peers Comparison

Ticker	Name	Value
WVE	WAVE Life Sciences Ltd	7775.20%
DPH.L	Dechra Pharmaceuticals PLC	56.41%
EOLS	Evolus Inc	68.46%
INDV.L	Indivior PLC	85.27%
KLDO	Kaleido Biosciences Inc	7775.20%
LYRA	Lyra Therapeutics Inc	7775.20%
VEC.L	Vectura Group PLC	5320.04%
AZN.L	AstraZeneca PLC	82.14%
CXRXF	Advanz Pharma Corp Ltd	63.41%
HIK.L	Hikma Pharmaceuticals PLC	45.88%
RDHL	Redhill Biopharma Ltd	47.03%
DRRX	DURECT Corp	96.16%
GWPRF	GW Pharmaceuticals PLC	91.26%
PLXP	PLx Pharma Inc	4146.00%
PRTK	Paratek Pharmaceuticals Inc	85.61%
APH.L	Alliance Pharma PLC	61.11%
CBAY	CymaBay Therapeutics Inc	7775.20%
TFFP	TFF Pharmaceuticals Inc	7775.20%
FULC	Fulcrum Therapeutics Inc	7775.20%
MIST	Milestone Pharmaceuticals Inc	7775.20%
EYPT	EyePoint Pharmaceuticals Inc	91.42%
ITRM	Iterum Therapeutics PLC	7775.20%
ORMP	Oramed Pharmaceuticals Inc	100.00%
XERS	Xeris Biopharma Holdings Inc	81.86%
ZYNE	Zynerba Pharmaceuticals Inc	7775.20%
AMPE	Ampio Pharmaceuticals Inc	7775.20%
CTXR	Citius Pharmaceuticals Inc	7775.20%
SEEL	Seelos Therapeutics Inc	80.95%
VYNE	Vyne Therapeutics Inc	93.38%
ATHA	Athira Pharma Inc	7775.20%
GSK.L	GSK plc	71.90%
RLMD	Relmada Therapeutics Inc	-
TARS	Tarsus Pharmaceuticals Inc	92.99%
CRMD	CorMedix Inc	92.66%
MMED.NE	Mind Medicine (MindMed) Inc	7775.20%